Jim Cramer Advises Focusing on Future Upside Over Past Gains in AI Stocks US Stock Futures and Treasury Yields Decline Amid Reports of Putins Updated Nuclear Doctrine Global Markets Brace for Potential TrumpXi Summit as Trade Tensions Loom Consumer Sentiment Plummets to Record Low in May as Inflation Fears Mount Amid Iran Conflict The Business of Travel Nursing How Mobile Healthcare Workers Are Reshaping Hospital Staffing Models BP Shares Dip as Board Removes Chairman Albert Manifold Over Conduct Concerns NeoVolta Inc NEOV Q1 2026 Earnings Narrowed Loss Beats Expectations Stock Climbs COYA Q1 2026 Earnings NarrowerThanExpected Loss Despite No Recognized Revenue PASG Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Progress CTNM Q1 2026 Earnings Narrower Loss Beats Estimates as PreRevenue Biotech Maintains Discipline BioRad BIO Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher Despite Headwinds GPC Q1 2026 Earnings Modest EPS Miss Amid Stable Operations International Paper IP Gains 131 as Stock Tests Key Resistance at 340 Coinbase Global COIN Slips Over 4 as Crypto Headwinds Intensify Soluna Holdings Preferred Stock SLNHP Edges Higher as It Approaches Key Resistance Level Seanergy Maritime SHIP Slides 23 as Dry Bulk Sector Faces Headwinds Support at 1412 in Focus Millrose Properties MRP Holds Steady Near Support as Consolidation Phase Emerges Technology Transforming Healthcare Sensors 3D Printing and Wearables Usher a New Medical Era OBK Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Northern Oil and Gas NOG Holds Steady Near Support Eyes Key Resistance Rapid7 Q1 2026 Earnings EPS Surpasses Estimates by 1765 Biohaven Ltd BHVN Q1 2026 Earnings Wider Loss Than Expected as PreRevenue Biotech Advances Pipeline NEUP Q1 2026 Earnings Narrowing Losses Beat Estimates Sharp Yet Shares Slip SPRB Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues CATY Q1 2026 Earnings Strong EPS Beat as Cathay General Bancorp Delivers 2275 Surprise MBX Q1 2026 Earnings Narrower Loss Exceeds Expectations Amid Clinical Development Progress DUOT Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction